Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
AIDS ; 18(6): 917-25, 2004 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-15060439

RESUMO

OBJECTIVE: To delineate the population attributable fraction (PAF) of transactional sex in prevalent cases of HIV infection in the male adult population of Accra, Ghana. DESIGN AND METHODS: Cross-sectional study of clients who visited a sex worker (SW), of boyfriends of SW and of male personnel in prostitution venues. A questionnaire was administered and urine obtained for detection of anti-HIV antibodies. The PAF of prevalent HIV acquired from SW was calculated using a combination of data from this survey of clients, from on-going SW surveys, the national HIV surveillance system and the national census. RESULTS: HIV prevalence was 4.9% (8/162) among clients of mobile SW, 15.8% (53/335) among clients of home-based SW, 17.5% (10/57) among personnel and 32.1% (9/28) among boyfriends. A condom was used in 90% of intercourses, according to clients. Non-use of a condom was clustered in selected locations and independently associated with older age of client, frequency of intercourse with SW in the last year and current urethritis. Among the male population of Accra aged 15-59 years, 84% of prevalent cases of HIV were attributable to transactional sex. A sensitivity analysis showed that under various assumptions PAF varied between 47% and 100%. CONCLUSIONS: In Accra, approximately four-fifths of prevalent cases of HIV in adult males were acquired from SW. Comprehensive interventions providing education, condoms and treatment for sexually transmitted diseases for SW and their clients should be approached as other public health priorities and provided in all cities, large and small, of West Africa.


Assuntos
Infecções por HIV/transmissão , Homossexualidade Masculina , Trabalho Sexual , Adolescente , Adulto , Preservativos , Estudos Transversais , Transmissão de Doença Infecciosa , Gana/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco
2.
PLoS One ; 6(9): e25082, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21949860

RESUMO

BACKGROUND: The spectrum of bacteria associated with bacterial vaginosis (BV) has recently expanded through taxonomic changes and the use of molecular methods. These methods have yet to be used in large-scale epidemiological studies in Africa where BV is highly prevalent. METHODS: An analysis of samples obtained during a clinical trial of the management of vaginal discharge in four West African countries. Samples were available from 1555 participants; 843 (54%) had BV. Nucleic acids of 13 bacterial genera or species potentially associated with BV were detected through the polymerase chain reaction. RESULTS: The associations between various components of the vaginal flora were complex. Excluding Lactobacillus, the other 12 micro-organisms were all associated with each other at the p≤0.001 level. The prevalence of various bacterial genera or species varied according to age, sexual activity and HIV status. In multivariate analysis, the presence of Gardnerella vaginalis, Bifidobacterium, Megasphaera elsdenii, Dialister, Mycoplasma hominis, Leptotrichia, and Prevotella were independently associated with BV as was the absence of Lactobacillus and Peptoniphilus. However, Mobiluncus, Atopobium vaginae, Anaerococcus, and Eggerthella were not independently associated with BV. Unexpectedly, after treatment with a regimen that included either metronidazole or tinidazole, the proportion of patients with a complete resolution of symptoms by day 14 increased with the number of bacterial genera or species present at enrolment. CONCLUSIONS: Numerous bacterial genera or species were strongly associated with each other in a pattern that suggested a symbiotic relationship. BV cases with a simpler flora were less likely to respond to treatment. Overall, the vaginal flora of West African women with BV was reminiscent of that of their counterparts in industrialized countries.


Assuntos
Bactérias/classificação , Bactérias/patogenicidade , Vagina/microbiologia , Vaginose Bacteriana/epidemiologia , Vaginose Bacteriana/microbiologia , Adulto , África/epidemiologia , Bactérias/genética , DNA Viral/genética , Estudos Epidemiológicos , Feminino , Humanos , Reação em Cadeia da Polimerase , Ensaios Clínicos Controlados Aleatórios como Assunto , Adulto Jovem
3.
J Acquir Immune Defic Syndr ; 51(2): 216-23, 2009 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-19339896

RESUMO

OBJECTIVE: To describe the epidemiology of HIV among core groups in Togo. METHODS: We enumerated sex workers (SWs) and conducted cross-sectional surveys of SWs and their clients in 2003 in Lomé and in 2005 in the whole country. RESULTS: Sex work was concentrated in Lomé, which comprised 15% of the population, but 52% of the 5397 SWs enumerated in Togo in 2005 and 68% of the estimated 101,376 men who had bought sex in the year before the 2005 survey. HIV prevalence among SWs was highest in Lomé (45.4% in 2005) and progressively decreased from south to north. A similar geographical pattern was seen for clients (8.3% were HIV infected in Lomé in 2005) and had already been reported for pregnant women. In Lomé, the population attributable fraction of prevalent cases of HIV acquired during transactional sex was estimated at 32%; in the rest of the country, this was only 2%. CONCLUSIONS: This is the first study quantifying sex work at a national level in Africa. Variations in HIV prevalence within Togo, with a north-south gradient among SWs, their clients, and pregnant women, may to a large extent reflect the concentration of the sex trade within Lomé. Prostitution played only a modest a role in HIV dynamics outside Lomé.


Assuntos
Infecções por HIV/epidemiologia , Infecções por HIV/transmissão , Adolescente , Adulto , Criança , Estudos Transversais , Transmissão de Doença Infecciosa , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Trabalho Sexual , Togo/epidemiologia , Adulto Jovem
4.
J Acquir Immune Defic Syndr ; 42(4): 490-3, 2006 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-16773025

RESUMO

BACKGROUND: Second-generation surveillance for HIV includes measures of high-risk behaviors among the general adult population and sex workers (SW). Questionnaires are prone to social desirability biases because individuals minimize the frequency of behaviors not expected from them. OBJECTIVE: Determine whether the prostate-specific antigen (PSA) could be used as a biological marker of unprotected intercourse. METHODS: We measured the presence of PSA in vaginal secretions of women who were (n = 508) or were not (n = 658) SW presenting with vaginal discharge in health facilities of Ghana, Togo, Guinea, and Mali. The cutoff for a positive assay was determined as > or =0.4 microg/L based on a subsample of 95 non-SW claiming abstinence for 3 months. RESULTS: A positive PSA assay was correlated with infections with Neisseria gonorrhoeae, Chlamydia trachomatis, and Mycoplasma genitalium. Among non-SW, a positive PSA was more common among those with HIV, but less frequent in those better educated. Among SW and non-SW, women from Ghana were less likely to have a positive PSA and had a lower prevalence of sexually transmitted infections than those from elsewhere. CONCLUSIONS: PSA can be used as a biological marker of unprotected intercourse, allowing interventions to target efforts on those at highest risk.


Assuntos
Antígeno Prostático Específico/análise , Sexo sem Proteção , Vagina/metabolismo , África Ocidental , Feminino , Humanos , Antígeno Prostático Específico/metabolismo
5.
Bull World Health Organ ; 84(9): 729-38, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17128343

RESUMO

OBJECTIVE: To evaluate whether single-dose treatments are as effective as standard therapy in the syndromic management of vaginal discharge. METHODS: A randomized controlled effectiveness trial compared single-dose tinidazole plus fluconazole (TF) with treatment for 7 days with metronidazole plus 3 days of treatment with vaginal clotrimazole (MC) among 1570 women presenting with vaginal discharge at primary health care institutions in Ghana, Guinea, Mali and Togo. Participants were randomly allocated to one of the two treatments by research nurses or physicians using precoded envelopes. Effectiveness was assessed by symptomatic response on day 14. CLINICAL IDENTIFIER ClinicalTrials.gov NCT00313131. FINDINGS: The two treatment regimens had similar effectiveness: complete resolution was seen in 66% (TF) and 64% (MC) and partial resolution in 33% (TF) and 34% (MC) of participants (P = 0.26). Effectiveness was similar among subgroups with vulvovaginal candidiasis, Trichomonas vaginalis vaginitis or bacterial vaginosis. The two treatment regimens had a similar effectiveness among human immunodeficiency virus (HIV)-infected (TF: n = 76, 71% complete resolution, 28% partial; MC: n = 83, 72% complete resolution, 25% partial, P = 0.76) and HIV-uninfected women (TF: n = 517, 68% complete, 32% partial; MC: n = 466, 65% complete, 33% partial, P = 0.20). Cervical infections with Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium were uncommon among women not involved in sex work, were associated with bacterial vaginosis or T. vaginalis vaginitis, and did not alter response to treatment with agents active against vaginal infections. Four-fifths of women not relieved by a single dose of TF had a favourable response when MC was administered as second-line treatment. CONCLUSION: Single-dose TF is as effective as multiple-dose MC in the syndromic management of vaginal discharge, even among women with HIV-infection. Given its low price and easier adherence, TF should be considered as a first-line treatment for vaginal discharge syndrome.


Assuntos
Anti-Infecciosos/administração & dosagem , Antifúngicos/administração & dosagem , Antitricômonas/administração & dosagem , Clotrimazol/administração & dosagem , Fluconazol/administração & dosagem , Metronidazol/administração & dosagem , Tinidazol/administração & dosagem , Resultado do Tratamento , Descarga Vaginal/tratamento farmacológico , Adolescente , Adulto , África Ocidental , Animais , Anti-Infecciosos/uso terapêutico , Antifúngicos/uso terapêutico , Antitricômonas/uso terapêutico , Candida/efeitos dos fármacos , Criança , Clotrimazol/uso terapêutico , Quimioterapia Combinada , Feminino , Fluconazol/uso terapêutico , Humanos , Metronidazol/uso terapêutico , Mycoplasma genitalium/efeitos dos fármacos , Neisseria gonorrhoeae/efeitos dos fármacos , Trabalho Sexual , Síndrome , Tinidazol/uso terapêutico , Trichomonas vaginalis/efeitos dos fármacos , Descarga Vaginal/microbiologia , Descarga Vaginal/parasitologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA